Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.

[1]  R. Moreau,et al.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. , 2019, Gastroenterology.

[2]  M. Volk,et al.  Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation. , 2019, Gastroenterology.

[3]  A. de Gottardi,et al.  Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis , 2019, Front. Immunol..

[4]  R. Jalan,et al.  Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis , 2017, Gut.

[5]  M. Pavesi,et al.  Clinical course and short‐term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[6]  M. Delano,et al.  The immune system's role in sepsis progression, resolution, and long‐term outcome , 2016, Immunological reviews.

[7]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[8]  P. Kamath,et al.  Acute-on-chronic liver failure in cirrhosis , 2016, Nature Reviews Disease Primers.

[9]  R. Moreau,et al.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.

[10]  A. Burroughs,et al.  Acute-on-chronic liver failure , 2015, The Lancet.

[11]  A. de Gottardi,et al.  Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis , 2015, Hepatology.

[12]  V. de Lédinghen,et al.  Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. , 2015, Journal of hepatology.

[13]  W. Kim,et al.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.

[14]  R. Moreau,et al.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. , 2014, Journal of hepatology.

[15]  X. Salvatella,et al.  Human serum albumin, systemic inflammation, and cirrhosis. , 2014, Journal of hepatology.

[16]  A. Burroughs,et al.  The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score , 2014, The American Journal of Gastroenterology.

[17]  M. Pavesi,et al.  Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short‐term risk of severe sepsis, hepatorenal syndrome, and death , 2013, Hepatology.

[18]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[19]  M. Pavesi,et al.  Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. , 2012, Journal of hepatology.

[20]  M. Pavesi,et al.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study , 2012, Hepatology.

[21]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  M. Navasa,et al.  Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. , 2007, Gastroenterology.

[23]  M. Navasa,et al.  Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis , 2002, Hepatology.

[24]  M. Navasa,et al.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.

[25]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[26]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.